BUYINS.NET: ARUN, GLRE, MPEL, OPTR, SMA, IHS Are Seasonally Ripe To Go Down In the Next Five Weeks
(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ARUBA NETWORKS INC (NASDAQ:ARUN), Greenlight Capital Re Ltd (NASDAQ:GLRE), Melco Crown Entertainment Limited (NASDAQ:MPEL), Optimer Pharmaceuticals Inc (NASDAQ:OPTR), Symmetry Medical Inc (NYSE:SMA), IHS INCORPORATION (NYSE:IHS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date
ARUN ARUBA NETWORKS INC -4.84% 100.00% (6 of 6) Tuesday, July 9th 2013
GLRE Greenlight Capital Re Ltd -1.50% 100.00% (6 of 6) Tuesday, July 9th 2013
MPEL Melco Crown Entertainment Limited -4.43% 100.00% (6 of 6) Tuesday, July 9th 2013
OPTR Optimer Pharmaceuticals Inc -3.25% 66.67% (4 of 6) Tuesday, July 9th 2013
SMA Symmetry Medical Inc -2.86% 87.50% (7 of 8) Tuesday, July 9th 2013
IHS IHS INCORPORATION -1.80% 85.71% (6 of 7) Tuesday, July 9th 2013
ARUBA NETWORKS INC (NASDAQ:ARUN) - Aruba Networks, Inc. provides network access solutions for the mobile enterprises worldwide. It offers ArubaOS, an operating system software for wired, wireless, and remote access products for integrating user-based security, application-aware radio-frequency services, and wireless local area network (LAN) access to deliver mobile networking solutions, as well as provides various software modules for ArubaOS. The company also offers Mobility Controllers, which provides context-aware networking across wireless and wired LANs, virtual private network (VPN) connections, and remote offices; ClearPass Access Management System for bring your own device provisioning and onboarding, as well as for IT-issued and personal mobile devices to connect to any network; Aruba Instant, a controller-less Wi-Fi solution; AirWave, a multivendor network management software that manages radio frequency (RF) environment, controllers, wired infrastructure, and access points; and Access Points, which offers integrated RF management, intrusion prevention, and support for maximum client density of smartphones and tablets. In addition, it provides Mobility Access Switches that brings context-based access to wired networks; Outdoor Mesh Routers for transporting voice, video, and other real-time applications across long distances; Wi-Fi-Aware Virtual Intranet Access Client, which provides remote network connectivity for mobile devices and laptops; and access on-ramps, including wireless, wired, and VPN products, as well as remote networking solutions. The company sells its products to general enterprise, higher education, K-12 education, finance, government, healthcare, hospitality, manufacturing, media, retail, high-technology, telecom, transportation, and utilities through its sales force, value-added resellers and distributors, and original equipment manufacturers. Aruba Networks, Inc. was incorporated in 2002 and is headquartered in Sunnyvale, California..
Greenlight Capital Re Ltd (NASDAQ:GLRE) - Greenlight Capital Re, Ltd., through its subsidiaries, operates in the property and casualty reinsurance business in the United States, Europe, the Caribbean, and internationally. The company s frequency business includes contracts containing smaller losses emanating from multiple events and enables the clients to increase their own underwriting capacity; and severity business comprises contracts with the potential for significant losses emanating from one event or multiple events. It offers personal, motor physical damage, and commercial; general, marine, motor, and professional liability; and financial, health, medical malpractice, and worker s compensation products. The company sells its products primarily through reinsurance brokers. Greenlight Capital Re, Ltd. was founded in 2004 and is based in Grand Cayman, the Cayman Islands..
Melco Crown Entertainment Limited (NASDAQ:MPEL) - Melco Crown Entertainment Limited, through its subsidiaries, engages in the development, ownership, and operation of casino gaming and entertainment resort facilities primarily in Macau. The company owns and operates City of Dreams, an integrated resort development, which features approximately 400 gaming tables and 1,300 gaming machines; guest rooms; a wet stage performance theater with approximately 2,000 seats; approximately 20 restaurants and bars, 70 retail outlets, and an audio visual multimedia experience; and recreation and leisure facilities, including health and fitness clubs, swimming pools, spa and salons, and banquet and meeting facilities. It also operates Altira Macau that features approximately 200 gaming tables; 216 guest rooms; and various non-gaming entertainment venues, including restaurants, several bars, a spa, gymnasium, outdoor garden podium, and a sky terrace lounge. In addition, the company owns and operates Mocha Clubs, which provide non-casino based operations of approximately 2,100 electronic gaming machines. It is also developing the Studio City Project, a cinematically-themed integrated entertainment, retail and gaming resort in Cotai, Macau. The company was formerly known as Melco PBL Entertainment (Macau) Limited and changed its name to Melco Crown Entertainment Limited in May 2008. Melco Crown Entertainment Limited was incorporated in 2004 and is based in Central, Hong Kong..
Optimer Pharmaceuticals Inc (NASDAQ:OPTR) - Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on development and commercialization of pharmaceutical products. It offers fidaxomicin tablets, an antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD). The company sells its fidaxomicin products through wholesalers to hospitals, retail, and specialty pharmacies in the United States. It also has fidaxomicin under Phase IIIB clinical trials for the treatment of CDAD prophylaxis and CDAD in oncology patients; and under Phase II clinical trials for the treatment of pediatric CDAD treatment. In addition, the company has Solithromycin product under Phase II clinical trials for the treatment of respiratory tract infections; and OPT-822/821 product under Phase II/III clinical trials for the treatment of breast cancer. It has collaborative agreements with Cubist Pharmaceuticals, Inc.; Astellas Pharma Europe Ltd.; Par Pharmaceuticals, Inc.; Biocon Limited; Patheon Inc.; Cempra Pharmaceuticals, Inc.; Optimer Biotechnology, Inc.; Memorial Sloan-Kettering Cancer Center; and Scripps Research Institute. The company was founded in 1998 and is based in San Diego, California..
Symmetry Medical Inc (NYSE:SMA) - Symmetry Medical Inc. and its subsidiaries designs, develops, and produces implants and related surgical instruments, and cases primarily to orthopedic device manufacturers worldwide. It offers orthopedic implants that are used in reconstructive surgeries to replace or repair hips, knees, and other joints, such as shoulders, ankles, and elbows; trauma implant systems, which are used primarily to reattach or stabilize damaged bone or tissue while the body heals; and spinal implant systems used by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and injuries in various regions of the spine. The company also produces surgical instruments, such as knee cutting blocks, osteotome revision systems, reamers, and retractors used in hip, knee, and shoulder reconstruction procedures, as well as in spinal, trauma, and other implant procedures. In addition, it offers a range of plastic, metal, and hybrid cases to store, transport, and arrange surgical instruments, related implant systems, and other medical devices for orthopedic device manufacturers; endoscopy cases for endoscope sterilization; dental cases used in dental implant and general dental procedures; sterilization containers for the sterilization of various surgical instruments; and other cases for arthroscopy, osteobiologic, cardiovascular, ophthalmology, and diagnostic imaging, as well as ear, nose, and throat procedures. Further, the company engages in the design, engineering, and manufacturing of aerospace products comprising net shaped aerofoils and non-rotating aircraft engine forgings for the aerospace customers, as well as offers aerospace machining capabilities. Symmetry Medical Inc. was founded in 1976 and is headquartered in Warsaw, Indiana..
IHS INCORPORATION (NYSE:IHS) - IHS Inc. provides critical information, insights, and analytics. It provides solutions in customer workflows, including strategy, planning, and analysis that offers information, research, and tools, which support a range of commercial decisions and processes comprising capital investments, country-entry strategies, acquisitions, annual strategic planning processes, and monthly/quarterly productions and sales forecasts; and energy technical workflow that provides information, software, and services for critical decisions. The company s customer workflows also include product design solutions that offer information and insight to design products, complete engineering projects, and solve technical problems; and supply chain solutions, which provide information, research and analysis, knowledge-enabled insight products, and advisory services that enable its customers to address the supply chain challenges. In addition, its customer workflows comprise environmental, health, safety, and sustainability solutions that enhance the critical decisions associated with environmental, health, and safety; operational risk; product stewardship; greenhouse gas; and corporate social responsibility. The company primarily serves government, multinational companies, small companies, and technical professionals in various industries, including energy and natural resources, chemicals, transportation, and electronics in the Americas; Europe, the Middle East, and Africa; and the Asia Pacific. IHS Inc. was founded in 1959 and is headquartered in Englewood, Colorado..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Thomas Ronk, CEO
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to firstname.lastname@example.org)).
(c) 2013 M2 COMMUNICATIONS
[ InfoTech Spotlight's Homepage ]